Core Points - The Bioeconomy Index (970038) closed at 2213.22 points on November 17, down 1.73% with a trading volume of 19.985 billion yuan and a turnover rate of 1.43% [1] - Among the index constituents, 7 stocks rose while 42 stocks fell, with Jingxin Pharmaceutical leading the gainers at 4.2% and Hualan Biological leading the decliners at 5.4% [1] Index Constituents Summary - The top ten constituents of the Bioeconomy Index include: - Mindray Medical (sz300760) with a weight of 12.58%, latest price at 206.04, down 0.80%, total market value of 249.811 billion yuan [1] - Changchun High-tech (sz000661) with a weight of 4.87%, latest price at 102.16, down 2.29%, total market value of 41.675 billion yuan [1] - Ten Years Aoshi (sz002252) with a weight of 4.74%, latest price at 6.82, down 0.73%, total market value of 45.271 billion yuan [1] - Kanglong Chemical (sz300759) with a weight of 4.55%, latest price at 29.80, down 5.34%, total market value of 52.990 billion yuan [1] - Tigermed (sz300347) with a weight of 4.54%, latest price at 55.58, down 4.01%, total market value of 47.856 billion yuan [1] - Deep Technology (sz000021) with a weight of 4.16%, latest price at 24.56, down 0.73%, total market value of 38.600 billion yuan [1] - Muyuan Foods (sz002714) with a weight of 3.62%, latest price at 48.46, down 2.83%, total market value of 264.726 billion yuan [1] - Lepu Medical (sz300003) with a weight of 3.19%, latest price at 16.32, down 2.74%, total market value of 30.084 billion yuan [1] - Aimeike (sz300896) with a weight of 3.16%, latest price at 155.95, down 1.05%, total market value of 47.189 billion yuan [1] - Sequoia Medical (sz002223) with a weight of 3.07%, latest price at 35.59, down 1.71%, total market value of 35.678 billion yuan [1] Capital Flow Analysis - The Bioeconomy Index constituents experienced a net outflow of 1.896 billion yuan from institutional investors, while retail investors saw a net inflow of 1.536 billion yuan [1] - The detailed capital flow for selected stocks includes: - Huace Testing (300012) with a net inflow of 25.405 million yuan from institutional investors [2] - Jingxin Pharmaceutical (002020) with a net inflow of 21.781 million yuan from institutional investors [2] - Pro Pharmaceutical (000739) with a net inflow of 4.350 million yuan from institutional investors [2] - Meiya Optoelectronics (002690) with a net inflow of 3.279 million yuan from institutional investors [2] - Kairui Medical (300633) with a net inflow of 3.268 million yuan from institutional investors [2]
11月17日生物经济(970038)指数跌1.73%,成份股华兰疫苗(301207)领跌